Organon (OGN) Divestments (2020 - 2026)
Organon (OGN) posted quarterly Divestments of $433.0 million for Q1 2026, up 43200.0% on a QoQ basis from $1.0 million in Q4 2020.
Organon (OGN) Divestments (2020 - 2026) Analysis & Trends
Organon has reported Divestments for 2 years, with the latest figure at $433.0 million in Q1 2026.
- Divestments for Q1 2026 came in at $433.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $433.0 million (changed N/A YoY), and the FY2020 annual result was -$8.0 million, up 42.86% from the prior year.
- Divestments rose to $433.0 million in Q1 2026, from $1.0 million in the prior quarter.
- Over five years, Divestments peaked at $433.0 million in Q1 2026 and troughed at $433.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.15 Bn | 631.39 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.22 Bn | 463.65 Bn | 12.70 Bn | - |
| 3 | Merck | 375.23 Bn | 368.09 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 302.74 Bn | 295.05 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.97 Bn | 222.98 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.72 Bn | 179.54 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | 1.88 Bn |
| 9 | Gsk | 106.14 Bn | 101.97 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433.00 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | -5.00 Mn |
| Jun 30, 2020 | 6.00 Mn |
| Mar 31, 2020 | -10.00 Mn |